Pharmalogic Idaho, LLC entered into an Asset Purchase Agreement to acquire Certain Assets of International Isotopes Inc. from International Isotopes Inc. (OTCPK:INIS) for $4 million on February 10, 2022. The consideration shall be paid in cash on closing. The transaction is subject to the buyer being satisfied with its due diligence review of the purchased assets and the execution of sublease and transitional services agreements. It is expected to close on or around February 18, 2022. David J. Champoux of Pierce Atwood LLP acted as legal advisor to Pharmalogic Idaho, LLC. Melanie G. Rubocki of Perkins Coie LLP acted as legal advisor to International Isotopes Inc.

Pharmalogic Idaho, LLC completed the acquisition of Certain Assets of International Isotopes Inc. from International Isotopes Inc. (OTCPK:INIS) on February 18, 2022.